Pregnancy Related Clinical Trial
— NELIPOfficial title:
A Participant Choice Approach to Improve Adherence and Investigate Pregnancy Outcomes to Lifestyle Interventions
NCT number | NCT06187675 |
Other study ID # | 123317 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | January 1, 2024 |
Est. completion date | November 2029 |
Interventions that target excessive gestational weight gain (EGWG) with nutrition and exercise behavior change struggle with low program adherence. The investigators recently examined adherence in a randomized controlled trial to a previously established lifestyle program called the Nutrition and Exercise Lifestyle Intervention Program (NELIP) and found that those individuals with high adherence to the program were more likely to prevent EGWG. Perhaps offering participants a choice to intervention strategies may improve adherence. The current research question is: What impact does participant choice have on adherence to the introduction of nutrition and exercise components during 3 intervention strategies offered to pregnant individuals compared to no choice and does choice maintain pregnancy health outcomes? The strategies are: Group A - introducing both the nutrition and exercise components simultaneous at baseline (12-18 weeks of pregnancy) that is followed to delivery (NELIP); Group B - introducing the nutrition component first and then at 25 weeks adding the exercise component; or Group C - starting with the exercise component first, followed with introducing the nutrition component at 25 weeks. Both Groups B and C follow the full NELIP from 25 weeks to delivery (final intervention measures will occur at 34-36 weeks gestation). Follow-up will occur at birth (6-18 hours), 2, 6 and 12 months post delivery.
Status | Recruiting |
Enrollment | 120 |
Est. completion date | November 2029 |
Est. primary completion date | December 2028 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - between 12 to 18 weeks of pregnancy - a singleton fetus - medically screened with the Get Active Questionnaire for Pregnancy to determine eligibility for participation in the exercise component Exclusion Criteria: - inability to walk - serious medical problems - high blood pressure - uncontrolled chest pain - uncontrolled symptomatic lung disease - diabetes before pregnancy - a history of recreational substance use disorder - any contraindication to exercise - enrolled in another clinical trial. |
Country | Name | City | State |
---|---|---|---|
Canada | Exercise and Pregnancy Lab, 2245, 3-M Centre - University of Western Ontario | London | Ontario |
Lead Sponsor | Collaborator |
---|---|
Western University, Canada |
Canada,
Mottola MF, Giroux I, Gratton R, Hammond JA, Hanley A, Harris S, McManus R, Davenport MH, Sopper MM. Nutrition and exercise prevent excess weight gain in overweight pregnant women. Med Sci Sports Exerc. 2010 Feb;42(2):265-72. doi: 10.1249/MSS.0b013e3181b5419a. — View Citation
Nagpal TS, Prapavessis H, Campbell C, Mottola MF. Measuring Adherence to a Nutrition and Exercise Lifestyle Intervention: Is Program Adherence Related to Excessive Gestational Weight Gain? Behav Anal Pract. 2017 May 17;10(4):347-354. doi: 10.1007/s40617-017-0189-5. eCollection 2017 Dec. — View Citation
Nagpal TS, Prapavessis H, Campbell CG, de Vrijer B, Bgeginski R, Hosein K, Paplinskie S, Manley M, Mottola MF. Sequential Introduction of Exercise First Followed by Nutrition Improves Program Adherence During Pregnancy: a Randomized Controlled Trial. Int J Behav Med. 2020 Feb;27(1):108-118. doi: 10.1007/s12529-019-09840-0. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Adherence to the intervention strategy | Percent of participants adherent to the strategies measured by a published Adherence Scale giving a score out of 3 for each component (nutrition and exercise). | Measured once per week from baseline (12-18 weeks gestation) to end of the intervention (34-36 weeks gestation) | |
Secondary | Participant satisfaction | Satisfaction Survey assessed on a 5-point Likert scale; ranging from 1 for very unsatisfied to 5 for very satisfied. | Measured at 34-36 weeks of pregnancy at the end of the intervention | |
Secondary | Gestational weight gain | Weight gained measured in kg and compared to the Institute of Medicine 2009 weight gain guidelines | Measured weekly from 12-18 weeks of pregnancy to 34-36 weeks of pregnancy | |
Secondary | Birth weight | Birth weight (measured in kg) | Measured within 6 to 18 hours after delivery | |
Secondary | Birth length | Birth Length (measured in cms) | Measured within 6 to 18 hours after delivery | |
Secondary | Birth circumferences | Newborn circumferences (arm, forearm, thigh, leg, abdomen, chest, and head - measured in cm) | Measured within 6 to 18 hours after delivery | |
Secondary | Birth skinfolds | Newborn skinfolds (biceps, triceps, subscapular, suprailiac, anterior thigh - measured in mm) | Measured within 6 to 18 hours after delivery | |
Secondary | Pregnancy outcome | APGAR scores (measured out of 10 at 1 minutes and 5 minutes after birth) | Measured within 6 to 18 hours after delivery | |
Secondary | Pregnancy complications | Pregnancy complications (recorded) | Measured within 6 to 18 hours after delivery | |
Secondary | Postpartum body weight | Participant body weight (measured in kg) | 2, 6 and 12 months after birth | |
Secondary | Follow-up Infant weight | Infant weight (measured in kg) | 2, 6 and 12 months after birth | |
Secondary | Follow-up Infant length | Infant length (measured in cm) | 2, 6 and 12 months after birth | |
Secondary | Follow-up Infant Girths | Infant circumferences (arm, forearm, thigh, leg, abdomen, chest, head - measured in cm) | 2, 6 and 12 months after birth | |
Secondary | Follow-up Infant adiposity | Infant skinfold measurements (biceps, triceps, subscapular, suprailiac, anterior thigh - measured in mm) | 2, 6 and 12 months after birth |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05017974 -
Research on Improving Sleep During Pregnancy
|
N/A | |
Completed |
NCT03284515 -
Vaccination In Pregnancy Gene Signature: VIP Signature Study
|
||
Recruiting |
NCT05969795 -
Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support
|
Phase 1 | |
Recruiting |
NCT06051201 -
Innovation for Small-scale Experiments: ReceptIVFity Test
|
N/A | |
Recruiting |
NCT04828382 -
Prospective Study of Pregnancy in Women With Cystic Fibrosis
|
||
Enrolling by invitation |
NCT04527926 -
STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy
|
N/A | |
Recruiting |
NCT04278651 -
Early Antenatal Support for Iron Deficiency Anemia
|
Phase 4 | |
Recruiting |
NCT04405700 -
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
|
||
Recruiting |
NCT06258902 -
Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
|
||
Completed |
NCT05487196 -
Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia
|
Phase 2 | |
Completed |
NCT03750968 -
Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects
|
Phase 2 | |
Enrolling by invitation |
NCT06127277 -
Next4You: A Fully Mobile Relationships Based Program for Youth in Foster Care
|
N/A | |
Completed |
NCT05897697 -
Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study
|
||
Recruiting |
NCT05899101 -
The Impact of Opioid and Cannabis Exposure on Fetal Growth
|
||
Completed |
NCT05502510 -
Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
|
||
Completed |
NCT04296396 -
Opioid Prescription After Cesarean Trial
|
Phase 3 | |
Not yet recruiting |
NCT06069856 -
Multiple Micronutrient Supplementation (MMS) IFA- Iron Dose Acceptability Crossover Trial
|
Phase 3 | |
Not yet recruiting |
NCT06069869 -
Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial
|
Phase 3 | |
Not yet recruiting |
NCT06079918 -
Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania
|
Phase 3 | |
Not yet recruiting |
NCT06163651 -
Evaluating a One-Year Version of the Parent-Child Assistance Program
|
N/A |